| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2725277 | The American Journal of Medicine | 2015 | 10 Pages |
Abstract
The choice of the proper antithrombotic treatment in patients with atrial fibrillation has to consider the net clinical benefit of each drug. However, all non-vitamin K antagonist oral anticoagulants have a better efficacy/safety profile than warfarin in patients with atrial fibrillation.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Giulia MD, PhD, Marta PhD, Raffaele MD, PhD,